ARCHIVES

Trimodality Therapy Improves Survival In Early Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director

March 17, 1995

Guest Editorial: Chernobyl Doctor’s Notes From Fukushima

April 1, 2011

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998